Menu

Antares Pharma, Inc. ATRS

Full chart Compare
Set alert

Price alert · ATRS

All alert types
5.59 +5.59

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue by
Other Income → Gross Profit & Other Income: $103.21MGross Profit & Other Income → Net Income: $46.29MGross Profit & Other Income → Selling, General & Admin: $73.86MGross Profit & Other Income → Research & Development: $14.50MGross Profit & Other Income → Other Operating Expenses: $68.28MGross Profit & Other Income → Income Tax: $15.98MProduct → Revenue: $126.67MGross Profit → Gross Profit & Other Income: $115.70MRevenue → Gross Profit: $115.70MRevenue → Cost of Revenue: $68.28MRoyalty → Revenue: $37.69MLicensing And Development Revenue → Revenue: $19.62MOther Income$103.21MGross Profit$115.70MCost of Revenue$68.28MGross Profit & Other Income$218.91MNet Income$46.29MSelling, General & Admin$73.86MResearch & Development$14.50MOther Operating Expenses$68.28MIncome Tax$15.98MRevenue$183.98MProduct$126.67MRoyalty$37.69MLicensing And Development Revenue$19.62M

Latest period ending Dec 31, 2021 · select a line to chart its full history

Annual income statement

ATRS annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
183.98M149.60M123.86M63.55M54.52M
183.98M149.60M123.86M63.55M54.52M
54.42M53.96M46.27M29.09M27.47M
129.56M95.64M77.60M34.46M27.05M
49.77M72.88M72.40M36.59M42.64M
14.50M10.12M10.62M12.33M11.85M
73.86M62.76M61.77M36.76M31.65M
79.80M22.76M5.20M-2.13M-15.59M
3.61M3.79M3.55M2.67M1.42M
15.98M-46.28M000
46.29M56.20M-2.03M-6.51M-16.74M
46.29M56.20M-2.03M-6.51M-16.74M
46.29M56.20M-2.03M-6.51M-16.74M
46.29M56.20M-2.03M-6.51M-16.74M
0.270.34-0.01-0.04-0.11
0.270.34-0.01-0.04-0.11
0.260.33-0.01-0.04-0.11
65.88M13.71M1.52M-3.84M-15.32M
65.88M13.71M1.52M-3.84M-15.32M
169.23M166.07M162.57M157.41M156.05M
174.73M170.16M162.57M157.41M156.05M